High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer
PurposeThe aim of this work was to evaluate outcomes and toxicities of high dose-rate (HDR) endoluminal brachytherapy in a cohort of esophageal cancer patients.Patients and methodsWe analyzed the records of 36 patients treated with HDR brachytherapy for histologically confirmed esophageal cancer. Br...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
31 May 2016
|
| In: |
Strahlentherapie und Onkologie
Year: 2016, Jahrgang: 192, Heft: 7, Pages: 458-466 |
| ISSN: | 1439-099X |
| DOI: | 10.1007/s00066-016-0979-7 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s00066-016-0979-7 Verlag, Volltext: https://link.springer.com/article/10.1007/s00066-016-0979-7 
|
| Verfasserangaben: | Nils H. Nicolay, Johanna Rademacher, Jan Oelmann-Avendano, Jürgen Debus, Peter E. Huber, Katja Lindel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1571187839 | ||
| 003 | DE-627 | ||
| 005 | 20220814094512.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180319s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00066-016-0979-7 |2 doi | |
| 035 | |a (DE-627)1571187839 | ||
| 035 | |a (DE-576)501187839 | ||
| 035 | |a (DE-599)BSZ501187839 | ||
| 035 | |a (OCoLC)1340994442 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Nicolay, Nils |e VerfasserIn |0 (DE-588)136200834 |0 (DE-627)694181277 |0 (DE-576)279367880 |4 aut | |
| 245 | 1 | 0 | |a High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer |c Nils H. Nicolay, Johanna Rademacher, Jan Oelmann-Avendano, Jürgen Debus, Peter E. Huber, Katja Lindel |
| 264 | 1 | |c 31 May 2016 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.03.2018 | ||
| 520 | |a PurposeThe aim of this work was to evaluate outcomes and toxicities of high dose-rate (HDR) endoluminal brachytherapy in a cohort of esophageal cancer patients.Patients and methodsWe analyzed the records of 36 patients treated with HDR brachytherapy for histologically confirmed esophageal cancer. Brachytherapy was either applied as a boost treatment for definitive treatment regimens or as salvage therapy for recurrent tumors with single doses between 4 and 6 Gy. Survival and toxicities were retrospectively analyzed.ResultsBrachytherapy was performed as initially planned in all but one patient; 18 patients had a complete endoscopic response at the first follow-up examination. Locoregional recurrence was observed in 24 patients after a median time of 3 months; 1‑ and 2‑year recurrence-free survival rates were 51 and 51 % for the patients treated for primary tumors and 11 and 6 % for patients treated for tumor recurrence, respectively. Median overall survival was 18 months; estimated overall survival rates at 1, 2, and 3 years were 63, 50, and 30 % after primary brachytherapy, and 60, 25, and 6 % after recurrence therapy. Adenocarcinoma histology, non-complete remission after treatment, and treatment for recurrent cancers were associated with significantly reduced prognoses. Mild dysphagia was the most common side effect in 17 patients; 8 patients suffered from locoregional grade 3 toxicities, and no grade 4 or 5 toxicities were observed.ConclusionsEndoluminal brachytherapy during the course of esophageal cancer treatment can be safely applied and results in good functional outcomes regarding dysphagia with low rates of severe toxicities. | ||
| 700 | 1 | |a Rademacher, Johanna |e VerfasserIn |0 (DE-588)1154710742 |0 (DE-627)1016112637 |0 (DE-576)50118709X |4 aut | |
| 700 | 1 | |a Oelmann-Avendano, Jan Tobias |e VerfasserIn |0 (DE-588)1058247352 |0 (DE-627)796657173 |0 (DE-576)414301110 |4 aut | |
| 700 | 1 | |a Debus, Jürgen |d 1964- |e VerfasserIn |0 (DE-588)1022671421 |0 (DE-627)717025780 |0 (DE-576)365774944 |4 aut | |
| 700 | 1 | |a Huber, Peter E. |d 1965- |e VerfasserIn |0 (DE-588)1074678869 |0 (DE-627)832350109 |0 (DE-576)442767803 |4 aut | |
| 700 | 1 | |a Lindel, Katja |d 1972- |e VerfasserIn |0 (DE-588)121342689 |0 (DE-627)705399176 |0 (DE-576)292658044 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Strahlentherapie und Onkologie |d Berlin : Springer Medizin, 1997 |g 192(2016), 7, Seite 458-466 |h Online-Ressource |w (DE-627)312407866 |w (DE-600)2003907-4 |w (DE-576)090884809 |x 1439-099X |7 nnas |a High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer |
| 773 | 1 | 8 | |g volume:192 |g year:2016 |g number:7 |g pages:458-466 |g extent:9 |a High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00066-016-0979-7 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00066-016-0979-7 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180319 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 121342689 |a Lindel, Katja |m 121342689:Lindel, Katja |d 910000 |d 911400 |e 910000PL121342689 |e 911400PL121342689 |k 0/910000/ |k 1/910000/911400/ |p 6 |y j | ||
| 998 | |g 1074678869 |a Huber, Peter E. |m 1074678869:Huber, Peter E. |d 50000 |e 50000PH1074678869 |k 0/50000/ |p 5 | ||
| 998 | |g 1022671421 |a Debus, Jürgen |m 1022671421:Debus, Jürgen |d 910000 |d 911400 |e 910000PD1022671421 |e 911400PD1022671421 |k 0/910000/ |k 1/910000/911400/ |p 4 | ||
| 998 | |g 1058247352 |a Oelmann-Avendano, Jan Tobias |m 1058247352:Oelmann-Avendano, Jan Tobias |d 910000 |d 911400 |e 910000PO1058247352 |e 911400PO1058247352 |k 0/910000/ |k 1/910000/911400/ |p 3 | ||
| 998 | |g 1154710742 |a Rademacher, Johanna |m 1154710742:Rademacher, Johanna |d 910000 |d 911400 |e 910000PR1154710742 |e 911400PR1154710742 |k 0/910000/ |k 1/910000/911400/ |p 2 | ||
| 998 | |g 136200834 |a Nicolay, Nils |m 136200834:Nicolay, Nils |d 910000 |d 911400 |e 910000PN136200834 |e 911400PN136200834 |k 0/910000/ |k 1/910000/911400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1571187839 |e 3003666339 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 19.03.2018"],"language":["eng"],"person":[{"display":"Nicolay, Nils","family":"Nicolay","role":"aut","given":"Nils"},{"given":"Johanna","display":"Rademacher, Johanna","family":"Rademacher","role":"aut"},{"given":"Jan Tobias","display":"Oelmann-Avendano, Jan Tobias","family":"Oelmann-Avendano","role":"aut"},{"display":"Debus, Jürgen","family":"Debus","role":"aut","given":"Jürgen"},{"display":"Huber, Peter E.","family":"Huber","role":"aut","given":"Peter E."},{"given":"Katja","display":"Lindel, Katja","family":"Lindel","role":"aut"}],"recId":"1571187839","id":{"doi":["10.1007/s00066-016-0979-7"],"eki":["1571187839"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Nils H. Nicolay, Johanna Rademacher, Jan Oelmann-Avendano, Jürgen Debus, Peter E. Huber, Katja Lindel"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"31 May 2016"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["1439-099X"],"zdb":["2003907-4"],"eki":["312407866"]},"recId":"312407866","origin":[{"publisher":"Springer Medizin ; Urban & Vogel","dateIssuedKey":"1997","publisherPlace":"Berlin ; Heidelberg ; [München]","dateIssuedDisp":"1997-"}],"disp":"High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancerStrahlentherapie und Onkologie","language":["ger"],"note":["Gesehen am 13.05.09"],"pubHistory":["Nachgewiesen 173.1997 -"],"part":{"volume":"192","text":"192(2016), 7, Seite 458-466","extent":"9","issue":"7","year":"2016","pages":"458-466"},"title":[{"title":"Strahlentherapie und Onkologie","title_sort":"Strahlentherapie und Onkologie","subtitle":"journal of radiation oncology, biology, physics"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"9 S."}],"title":[{"title_sort":"High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer","title":"High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer"}]} | ||
| SRT | |a NICOLAYNILHIGHDOSERA3120 | ||